File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.hoc.2019.09.007
- Scopus: eid_2-s2.0-85074498607
- PMID: 31739938
- WOS: WOS:000500410200007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Radiation Therapy for Thoracic Malignancies
Title | Radiation Therapy for Thoracic Malignancies |
---|---|
Authors | |
Keywords | Chemotherapy Immune checkpoint inhibitors Non–small cell lung cancer Radiation techniques Targeted therapy |
Issue Date | 2020 |
Publisher | WB Saunders Co. The Journal's web site is located at http://www.hemonc.theclinics.com/ |
Citation | Hematology/Oncology Clinics of North America, 2020, v. 34 n. 1, p. 109-125 How to Cite? |
Abstract | Radiotherapy is the most commonly used nonsurgical modality in treatment of lung cancers, non-small cell lung cancer (NSCLC) in particular. Radiation therapy has been increasingly used as definitive radical treatment, either alone or in combination with concurrent chemoradiation for locally advanced disease. More recently with the advent of novel radiation techniques and modalities such as stereotactic radiotherapy and proton therapy, radiotherapy can now be used as sole radical treatment of small solitary tumors. This article reviews the current indications and future directions of radiotherapy in lung cancer management. |
Persistent Identifier | http://hdl.handle.net/10722/294031 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.705 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, VHF | - |
dc.contributor.author | Yang, L | - |
dc.contributor.author | Jiang, Y | - |
dc.contributor.author | Kong, FMS | - |
dc.date.accessioned | 2020-11-23T08:25:22Z | - |
dc.date.available | 2020-11-23T08:25:22Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Hematology/Oncology Clinics of North America, 2020, v. 34 n. 1, p. 109-125 | - |
dc.identifier.issn | 0889-8588 | - |
dc.identifier.uri | http://hdl.handle.net/10722/294031 | - |
dc.description.abstract | Radiotherapy is the most commonly used nonsurgical modality in treatment of lung cancers, non-small cell lung cancer (NSCLC) in particular. Radiation therapy has been increasingly used as definitive radical treatment, either alone or in combination with concurrent chemoradiation for locally advanced disease. More recently with the advent of novel radiation techniques and modalities such as stereotactic radiotherapy and proton therapy, radiotherapy can now be used as sole radical treatment of small solitary tumors. This article reviews the current indications and future directions of radiotherapy in lung cancer management. | - |
dc.language | eng | - |
dc.publisher | WB Saunders Co. The Journal's web site is located at http://www.hemonc.theclinics.com/ | - |
dc.relation.ispartof | Hematology/Oncology Clinics of North America | - |
dc.subject | Chemotherapy | - |
dc.subject | Immune checkpoint inhibitors | - |
dc.subject | Non–small cell lung cancer | - |
dc.subject | Radiation techniques | - |
dc.subject | Targeted therapy | - |
dc.title | Radiation Therapy for Thoracic Malignancies | - |
dc.type | Article | - |
dc.identifier.email | Lee, VHF: vhflee@hku.hk | - |
dc.identifier.email | Kong, FMS: kong0001@hku.hk | - |
dc.identifier.authority | Lee, VHF=rp00264 | - |
dc.identifier.authority | Kong, FMS=rp02508 | - |
dc.identifier.doi | 10.1016/j.hoc.2019.09.007 | - |
dc.identifier.pmid | 31739938 | - |
dc.identifier.scopus | eid_2-s2.0-85074498607 | - |
dc.identifier.hkuros | 319533 | - |
dc.identifier.volume | 34 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 109 | - |
dc.identifier.epage | 125 | - |
dc.identifier.isi | WOS:000500410200007 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0889-8588 | - |